by Icon Communications | Nov 29, 2017 | Business News
On 21 November 2017, Equra Health PTY LTD and the Lenmed Royal Hospital and Heart Centre will take delivery of the Elekta Synergy Platform, a radiation therapy treatment system that will revolutionise oncology in the Northern Cape Province. This state-of-the-art...
by Icon Communications | Nov 29, 2017 | Clinical Expert
The Faculty of Clinical Oncology of the Royal College of Radiologists published a comprehensive review on evidence-base Radiotherapy Dose Fractionation in December 2016....
by Icon Communications | Oct 19, 2017 | Business News
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a multi-disciplinary professional membership society that focuses on the benefits of therapeutic and diagnostic such as medicine within the spheres of policy, science and economics,...
by Icon Communications | Sep 13, 2017 | Clinical Expert
Belinda Bailey and David Eedes of Icon were invited to present the ICON Chemotherapy Administration Standards & Guidelines to delegates on the recent SASCRO/SASMO 2017 Conference. They would like to share the slide set and abstract from the prestigious national...
Johannesburg Gets State-of-the-Art Full-Service Oncology Centre.Icon Oncology delivers another first for Gauteng Johannesburg, June 20, 2024: Icon Oncology, the leading provider of oncology services in South Africa, proudly announces the grand opening of ... READ MORE
Wigs for cancer patientsSocial development grant grows skilled wigmakers A cancer diagnosis comes as a shock; it is a life-changing event and can cause feelings of despair and anxiety. When a patient is diagnosed, the ... READ MORE
Royal College of Radiologists Radiotherapy Dose Fractionation 2nd Edition PublishedThe Faculty of Clinical Oncology of the Royal College of Radiologists published a comprehensive review on evidence-base Radiotherapy Dose Fractionation in December 2016.... READ MORE
New oncology centre brings world-class cancer treatment to the KZN South Coast
MSH progress gains momentum in cancer treatmentMedical Specialist Holdings (MSH) has achieved a number of cancer treatment milestones in 2018, all of which are positive indicators of greater progress in 2019. In 2018, we were successful as a ... READ MORE